Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History ITRM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics ITRM

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Iterum Therapeutics PLC

ITRM
Current price
0.96 USD -0.0061 USD (-0.63%)
Last closed 0.97 USD
ISIN IE000TTOOBX0
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 38 556 000 USD
Yield for 12 month -25.85 %
1Y
3Y
5Y
10Y
15Y
ITRM
21.11.2021 - 28.11.2021

Iterum Therapeutics plc, a pharmaceutical company, develops and commercializes treatments for drug resistant bacterial infections in Ireland, Bermuda, and the United States. The company offers ORLYNVAH, an oral penem antibiotic for the treatment of uncomplicated urinary tract infections caused by Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis microorganisms in adult women with limited or no alternative oral antibacterial treatment options. It is also developing sulopenem, a novel anti-infective compound with oral and intravenous formulations to treat uncomplicated urinatry tract infections, complicated urinary tract infections, and complicated intra-abdominal infections, as well as community-acquired bacterial pneumonia, acute bacterial prostatitis, gonococcal urethritis, and pelvic inflammatory diseases. Iterum Therapeutics plc was incorporated in 2015 and is headquartered in Dublin, Ireland. Address: 3 Dublin Landings, Dublin, Ireland, D01 C4E0

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

7.00 USD

P/E Ratio

Dividend Yield

Financials ITRM

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures ITRM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-254 000 USD

Last Year

-1 750 000 USD

Current Quarter

-342 000 USD

Last Quarter

-239 000 USD
EBITDA -15 617 000 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -38.60 %
PEG Ratio
Return On Equity TTM -555.68 %
Wall Street Target Price 7.00 USD
Revenue TTM
Book Value -0.072 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -100.00 %
Dividend Yield
Gross Profit TTM -596 000 USD
Earnings per share -0.94 USD
Diluted Eps TTM -0.94 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation ITRM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 105.22
Price Sales TTM 1 349.79
Enterprise Value EBITDA 0.55
Price Book MRQ 6.03

Technical Indicators ITRM

For 52 Weeks

0.81 USD 3.02 USD
50 Day MA 1.02 USD
Shares Short Prior Month 1 076 103
200 Day MA 1.34 USD
Short Ratio 2.18
Shares Short 1 167 840
Short Percent 2.98 %